Core Viewpoint - Wanbang Pharmaceutical (301520) is actively monitoring opportunities in the upstream and downstream industrial layout of its main business, ensuring compliance with relevant laws and regulations, and confirming that there are no undisclosed significant matters [1] Summary by Categories - Business Strategy - The company is focused on the industrial layout opportunities related to its main business [1] - Regulatory Compliance - The company strictly adheres to relevant laws and regulations, indicating a commitment to transparency and governance [1] - Disclosure Practices - The company assures that it will fulfill its information disclosure obligations in a timely manner if any significant matters arise that require disclosure [1]
万邦医药：公司一直关注主营业务上下游的产业布局机会